{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:14:15Z","timestamp":1740107655536,"version":"3.37.3"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2021,11,12]],"date-time":"2021-11-12T00:00:00Z","timestamp":1636675200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,11,12]],"date-time":"2021-11-12T00:00:00Z","timestamp":1636675200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1007\/s00467-021-05288-1","type":"journal-article","created":{"date-parts":[[2021,11,12]],"date-time":"2021-11-12T10:02:35Z","timestamp":1636711355000},"page":"1575-1584","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Long-term obesity prevalence and linear growth in children with idiopathic nephrotic syndrome: is normal growth and weight control possible with steroid-sparing drugs and low-dose steroids for relapses?"],"prefix":"10.1007","volume":"37","author":[{"given":"Nil\u00fcfer","family":"G\u00f6knar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hazel","family":"Webb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aoife","family":"Waters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6234-6221","authenticated-orcid":false,"given":"Kjell","family":"Tullus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,11,12]]},"reference":[{"key":"5288_CR1","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3389\/fped.2016.00039","volume":"4","author":"R Chanchlani","year":"2016","unstructured":"Chanchlani R, Parekh RS (2016) Ethnic differences in childhood nephrotic syndrome. Front Pediatr 4:39. https:\/\/doi.org\/10.3389\/fped.2016.00039","journal-title":"Front Pediatr"},{"key":"5288_CR2","doi-asserted-by":"publisher","unstructured":"Hahn D, Hodson EM, Willis NS, Craig JC (2015) Corticosteroid therapy for nephrotic syndrome in children. Cochrane Database Syst Rev 18:CD001533. https:\/\/doi.org\/10.1002\/14651858.CD001533.pub5","DOI":"10.1002\/14651858.CD001533.pub5"},{"key":"5288_CR3","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1007\/s13312-012-0220-4","volume":"49","author":"A Sinha","year":"2012","unstructured":"Sinha A, Hari P, Sharma PK, Gulati A et al (2012) Disease course in steroid sensitive nephrotic syndrome. Indian Pediatr 49:881\u2013887. https:\/\/doi.org\/10.1007\/s13312-012-0220-4","journal-title":"Indian Pediatr"},{"key":"5288_CR4","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jpeds.2005.03.050","volume":"147","author":"EM R\u00fcth","year":"2005","unstructured":"R\u00fcth EM, Kemper MJ, Leumann EP, Laube GF et al (2005) Children with steroid-sensitive nephrotic syndrome come of age: long term outcome. J Pediatr 147:202\u2013207. https:\/\/doi.org\/10.1016\/j.jpeds.2005.03.050","journal-title":"J Pediatr"},{"key":"5288_CR5","doi-asserted-by":"publisher","first-page":"166","DOI":"10.5414\/CN108044","volume":"81","author":"P Skrzypczk","year":"2014","unstructured":"Skrzypczk P, Panczyk-Tomaszewska M, Roskowska-Blaim M, Wawer Z et al (2014) Long-term outcomes in idiopathic nephrotic syndrome: from childhood to adulthood. Clin Nephrol 81:166\u2013173. https:\/\/doi.org\/10.5414\/CN108044","journal-title":"Clin Nephrol"},{"key":"5288_CR6","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s00467-014-2955-8","volume":"30","author":"K Ishikura","year":"2015","unstructured":"Ishikura K, Yoshikawa N, Nakazato H, Sasaki S, Nakanishi K, Matsuyama T, Ito S, Hamasaki Y, Yata N, Ando T, Iijima K, Honda M, Japanese Study Group of Renal Disease in Children (2015) Morbidity in children with frequently relapsing nephrosis: 10-year follow-up of a randomized controlled trial. Pediatr Nephrol 30:459\u2013468. https:\/\/doi.org\/10.1007\/s00467-014-2955-8","journal-title":"Pediatr Nephrol"},{"key":"5288_CR7","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1136\/archdischild-2015-308924","volume":"101","author":"N Larkins","year":"2016","unstructured":"Larkins N, Kim S, Craig J, Hodson E (2016) Steroid-sensitive nephrotic syndrome: an evidence-based update of immunosuppressive treatment in children. Arch Dis Child 101:404\u2013408. https:\/\/doi.org\/10.1136\/archdischild-2015-308924","journal-title":"Arch Dis Child"},{"key":"5288_CR8","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1007\/s00467-020-04609-0","volume":"36","author":"EY Chan","year":"2021","unstructured":"Chan EY, Tullus K (2021) Rituximab in children with steroid sensitive nephrotic syndrome: in quest of the optimal regimen. Pediatr Nephrol 36:1397\u20131405. https:\/\/doi.org\/10.1007\/s00467-020-04609-0","journal-title":"Pediatr Nephrol"},{"key":"5288_CR9","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1007\/s00467-011-1830-0","volume":"26","author":"S Azib","year":"2011","unstructured":"Azib S, Macher MA, Kwon T, Dechatres A et al (2011) Cyclophosphamide in steroid dependant nephrotic syndrome. Pediatr Nephrol 26:927\u2013932. https:\/\/doi.org\/10.1007\/s00467-011-1830-0","journal-title":"Pediatr Nephrol"},{"key":"5288_CR10","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.kint.2017.08.011","volume":"93","author":"MP Gruppen","year":"2018","unstructured":"Gruppen MP, Bouts AH, Jansen-van der Weide MC, Merkus MP et al (2018) A randomized clinical trial indicates that levamisole increases the time to relaps in children with steroid-sensitive nephrotic syndrome. Kidney Int 93:510\u2013518. https:\/\/doi.org\/10.1016\/j.kint.2017.08.011","journal-title":"Kidney Int"},{"key":"5288_CR11","doi-asserted-by":"publisher","unstructured":"Boudin V, Alberti C, Lepayraque AL, Bensman A et al (2012) Mycophenolate mofetil for steroid-dependant nephrotic syndrome: a phase II Bayesian trial. Pediatr Nephrol 389-396https:\/\/doi.org\/10.1007\/s00467-011-2006-7","DOI":"10.1007\/s00467-011-2006-7"},{"key":"5288_CR12","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s00467-016-3458-6","volume":"32","author":"K Raya","year":"2017","unstructured":"Raya K, Parikh A, Webb H, Hothi D (2017) Use of a low-dose prednisolone regimen to treat a relapse of steroid-sensitive nephrotic syndrome in children. Pediatr Nephrol 32:99\u2013105. https:\/\/doi.org\/10.1007\/s00467-016-3458-6","journal-title":"Pediatr Nephrol"},{"key":"5288_CR13","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1007\/s00467-018-4119-8","volume":"34","author":"T Korsgaard","year":"2019","unstructured":"Korsgaard T, Andersen RF, Joshi S, Hagstrom S et al (2019) Childhood onset steroid sensitive nephrotic syndrome continues into adulthood. Pediatr Nephrol 34:641\u2013648. https:\/\/doi.org\/10.1007\/s00467-018-4119-8","journal-title":"Pediatr Nephrol"},{"key":"5288_CR14","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1007\/s00467-006-0100-z","volume":"21","author":"BJ Foster","year":"2006","unstructured":"Foster BJ, Shults J, Zemel BS, Leonard MB (2006) Risk factors for glucocorticoid-induced obesity in children with steroid-sensitive nephrotic syndrome. Pediatr Nephrol 21:973\u2013980. https:\/\/doi.org\/10.1007\/s00467-006-0100-z","journal-title":"Pediatr Nephrol"},{"key":"5288_CR15","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1177\/000992288602500304","volume":"25","author":"RJ Merritt","year":"1986","unstructured":"Merritt RJ, Hack SL, Kalsch M, Olson D (1986) Corticosteroid therapy-induced obesity in children. Clin Pediatr 25:149\u2013152. https:\/\/doi.org\/10.1177\/000992288602500304","journal-title":"Clin Pediatr"},{"key":"5288_CR16","unstructured":"WHO Multicentre Growth Reference Study Group (2006) WHO Child Growth Standards: length\/height-for-age, weight-for-age, weight-for-length, weight-for-height and body mass index-for-age: methods and development. World Health Organization. https:\/\/www.who.int\/publications\/i\/item\/924154693X. Accessed 11 November 2006"},{"key":"5288_CR17","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1136\/adc.2007.129957","volume":"95","author":"J Simmonds","year":"2010","unstructured":"Simmonds J, Grundy N, Trompeter R, Tullus K (2010) Long-term steroid treatment and growth: a study in steroid-dependant nephrotic syndrome. Arch Dis Child 95:146\u2013149. https:\/\/doi.org\/10.1136\/adc.2007.129957","journal-title":"Arch Dis Child"},{"key":"5288_CR18","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1007\/s00467-003-1176-3","volume":"18","author":"F Emma","year":"2003","unstructured":"Emma F, Sesto A, Rizzoni G (2003) Long term growth of children with severe steroid-responsive nephrotic syndrome. Pediatr Nephrol 18:783\u2013788. https:\/\/doi.org\/10.1007\/s00467-003-1176-3","journal-title":"Pediatr Nephrol"},{"key":"5288_CR19","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1007\/s00467-018-3963-x","volume":"34","author":"G Deschenes","year":"2019","unstructured":"Deschenes G, Dossier C, Hogan J (2019) Treating the idiopathic nephrotic syndrome: are steroids the answer? Pediatr Nephrol 34:777\u2013785. https:\/\/doi.org\/10.1007\/s00467-018-3963-x","journal-title":"Pediatr Nephrol"},{"key":"5288_CR20","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/BF00866783","volume":"10","author":"SM Feld","year":"1996","unstructured":"Feld SM, Hirschberg R (1996) Insulin-like growth factor-I and insulin-like growth factor-binding proteins in the nephrotic syndrome. Pediatr Nephrol 10:355\u2013358. https:\/\/doi.org\/10.1007\/BF00866783","journal-title":"Pediatr Nephrol"},{"key":"5288_CR21","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1056\/nejmoa040367","volume":"351","author":"MB Leonard","year":"2004","unstructured":"Leonard MB, Feldman H, Shults J, Zemel BS et al (2004) Long-term, high-dose glucocorticoids and bone mineral content in childhood glucocorticoid sensitive nephrotic syndrome. N Eng J Med 351:868\u2013875. https:\/\/doi.org\/10.1056\/nejmoa040367","journal-title":"N Eng J Med"},{"key":"5288_CR22","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1111\/j.1442-200x.2007.02429.x","volume":"49","author":"O Motoyama","year":"2007","unstructured":"Motoyama O, Itaka K (2007) Final height in children with steroid-sensitive nephrotic syndrome. Pediatr Int 49:623\u2013625. https:\/\/doi.org\/10.1111\/j.1442-200x.2007.02429.x","journal-title":"Pediatr Int"},{"key":"5288_CR23","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jpeds.2005.03.050","volume":"147","author":"EM R\u00fcth","year":"2005","unstructured":"R\u00fcth EM, Kemper MJ, Leumann EP, Laube GF et al (2005) Children with steroid-sensitive nephroic syndrome come of age: long-term outcome. J Pediatr 147:202\u2013207. https:\/\/doi.org\/10.1016\/j.jpeds.2005.03.050","journal-title":"J Pediatr"},{"key":"5288_CR24","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1007\/s00467-009-1301-z","volume":"24","author":"LT Donatti","year":"2009","unstructured":"Donatti LT, Koch VH (2009) Final height of adults with childhood-onset steroid-responsive idiopathic nephrotic syndrome. Pediatr Nephrol 24:2401\u20132408. https:\/\/doi.org\/10.1007\/s00467-009-1301-z","journal-title":"Pediatr Nephrol"},{"key":"5288_CR25","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.jped.2018.07.014","volume":"96","author":"E Valavi","year":"2018","unstructured":"Valavi E, Aminzadeh M, Amouri P, Rezazadeh A et al (2018) Effecs of prednisolone on linear growth in children with nephrotic syndrome. J Pediatr 96:117\u2013124. https:\/\/doi.org\/10.1016\/j.jped.2018.07.014","journal-title":"J Pediatr"},{"key":"5288_CR26","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1007\/s004670000338","volume":"14","author":"RI Gafni","year":"2000","unstructured":"Gafni RI, Baron J (2000) Catch-up growth: possible mechanisms. Pediatr Nephrol 14:616\u2013619. https:\/\/doi.org\/10.1007\/s004670000338","journal-title":"Pediatr Nephrol"},{"key":"5288_CR27","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/S0272-6386(87)80087-2","volume":"9","author":"JS Berns","year":"1987","unstructured":"Berns JS, Gaudio KM, Krassner LS, Anderson FP et al (1987) Steroid-responsive nephrotic syndrome of childhood: a long-term study of clinical course, histopathology, efficacy of cyclophosphamide therapy, and effects on growth. Am J Kidney Dis 9:108\u2013114","journal-title":"Am J Kidney Dis"},{"key":"5288_CR28","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1542\/peds.84.3.495","volume":"84","author":"R Padilla","year":"1989","unstructured":"Padilla R, Brem AS (1989) Linear growth of children with nephrotic syndrome: effect of alkylating agents. Pediatrics 84:495\u2013499","journal-title":"Pediatrics"},{"key":"5288_CR29","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1038\/ki.2012.280","volume":"82","author":"J Radhakrishnan","year":"2012","unstructured":"Radhakrishnan J, Cattran DC (2012) The KDIGO practice guideline on glomerulonephritis: reading between the (guide)lines\u2013application to the individual patient. Kidney Int 82:840\u2013856. https:\/\/doi.org\/10.1038\/ki.2012.280","journal-title":"Kidney Int"},{"key":"5288_CR30","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1007\/s00431-014-2479-z","volume":"174","author":"D Ribeiro","year":"2015","unstructured":"Ribeiro D, Zawadaynski S, Pittet LF, Chevalley T et al (2015) Effect of glucocorticoids on growth and bone mineral density in children with nephrotic syndrome. Eur J Pediatr 174:911\u2013917","journal-title":"Eur J Pediatr"},{"key":"5288_CR31","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1007\/s00467-014-2792-9","volume":"29","author":"M Sato","year":"2014","unstructured":"Sato M, Ito S, Ogura M, Kamei K (2014) Impact of rituximab on height and weight in children with refractory steroid-dependant nephrotic syndrome. Pediatr Nephrol 29:1373\u20131379. https:\/\/doi.org\/10.1007\/s00467-014-2792-9","journal-title":"Pediatr Nephrol"},{"key":"5288_CR32","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1177\/000992288802700807","volume":"27","author":"AY Elzouki","year":"1988","unstructured":"Elzouki AY, Jaiswal OP (1988) Long-term, small dose prednisone therapy in frequently relapsing nephrotic syndrome of childhood. Effect on remission, statural growth, obesity and infection rate. Clin Pediatr (Phila) 27:387\u2013392. https:\/\/doi.org\/10.1177\/000992288802700807","journal-title":"Clin Pediatr (Phila)"},{"key":"5288_CR33","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1053\/ajkd.2003.50116","volume":"41","author":"F Fakhouri","year":"2003","unstructured":"Fakhouri F, Bocquet N, Taupin P, Presne C et al (2003) Steroid-sensitive nephrotic syndrome: from childhood to adulthood. Am J Kidney Dis 41:550\u2013557. https:\/\/doi.org\/10.1053\/ajkd.2003.50116","journal-title":"Am J Kidney Dis"},{"key":"5288_CR34","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1007\/s004670050709","volume":"13","author":"K Scharer","year":"1999","unstructured":"Scharer K, Essigman HC, Schaefer F (1999) Body growth of children with steroid-resistant nephrotic syndrome. Pediatr Nephrol 13:829\u2013834. https:\/\/doi.org\/10.1007\/s004670050709","journal-title":"Pediatr Nephrol"},{"key":"5288_CR35","doi-asserted-by":"publisher","first-page":"CD001533","DOI":"10.1002\/14651858.CD001533.pub5","volume":"2015","author":"D Hahn","year":"2015","unstructured":"Hahn D, Hodson EM, Willis NS, Craig JC (2015) Corticosteroid therapy for nephrotic syndrome in children. Cochrane Database Syst Rev 2015:CD001533. https:\/\/doi.org\/10.1002\/14651858.CD001533.pub5","journal-title":"Cochrane Database Syst Rev"},{"key":"5288_CR36","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/ki.2014.240","volume":"87","author":"A Sinha","year":"2015","unstructured":"Sinha A, Saha A, Kumar M, Sharma S et al (2015) Extending initial prednisolone treatment in a randomized control trial from 3 to 6 months did not significantly influence the course of illness in children with steroid sensitive nephrotic syndrome. Kidney Int 87:217\u2013224. https:\/\/doi.org\/10.1038\/ki.2014.240","journal-title":"Kidney Int"},{"key":"5288_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta23260","volume":"23","author":"NJ Webb","year":"2019","unstructured":"Webb NJ, Woolley RL, Lambe T, Frew W et al (2019) Sixteen-week versus standard eight-week prednisolone therapy for childhood nephrotic syndrome: the Prednos RCT. Health Technol Assess 23:1\u2013108. https:\/\/doi.org\/10.3310\/hta23260","journal-title":"Health Technol Assess"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-021-05288-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00467-021-05288-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-021-05288-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,13]],"date-time":"2022-06-13T07:12:09Z","timestamp":1655104329000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00467-021-05288-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,12]]},"references-count":37,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["5288"],"URL":"https:\/\/doi.org\/10.1007\/s00467-021-05288-1","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"type":"print","value":"0931-041X"},{"type":"electronic","value":"1432-198X"}],"subject":[],"published":{"date-parts":[[2021,11,12]]},"assertion":[{"value":"10 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study complied with the Declaration of Helsinki and was approved by the institutional audit review committee of Great Ormond Street Children\u2019s Hospital.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}